Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vadim Pokrovsky

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Lancet (London, England)|October 6, 2017
Tuberculosis and HIV/AIDS: the alien and the predatorVadim Pokrovsky
International Journal of Molecular Sciences|July 12, 2025
New Anticancer Agents: Design, Synthesis and EvaluationVadim Pokrovsky, Raffaele Addeo, Mauro Coluccia
F1000Research|June 26, 2023
Predictive value of <sup>18</sup>F-fluorodeoxyglucose accumulation in visceral fat activity to detect colorectal cancer metastases (prospective observational cohort study)Amil Suleimanov, Aigul Saduakassova, Denis Vinnikov, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|October 23, 2020
Power of two: combination of therapeutic approaches involving glucose transporter (GLUT) inhibitors to combat cancerKalpana Tilekar, Neha Upadhyay, Cristina V Iancu, et al.
Cells|February 7, 2018
Optimization of Polycistronic Anti-CCR5 Artificial microRNA Leads to Improved Accuracy of Its Lentiviral Vector Transfer and More Potent Inhibition of HIV-1 in CD4⁺ T-CellsFelix Urusov, Dina Glazkova, Denis Omelchenko, et al.
Microorganisms|November 27, 2021
Dynamics of Plasmatic Levels of Pro- and Anti-Inflammatory Cytokines in HIV-Infected Individuals with <i>M. tuberculosis</i> Co-InfectionMarina Nosik, Konstantin Ryzhov, Irina Rymanova, et al.
Virus Evolution|July 1, 2022
Molecular epidemiology of HIV-1 in Oryol Oblast, RussiaKsenia R Safina, Yulia Sidorina, Natalya Efendieva, et al.
Cancer Communications (London, England)|October 17, 2022
Cell models with inducible oncogenic translocations allow to evaluate the potential of drugs to favor secondary translocationsAnna Shmakova, Nikolai Lomov, Vladimir Viushkov, et al.
Hepatic Medicine : Evidence and Research|May 6, 2020
Elbasvir/Grazoprevir for HCV Infection in Russia: A Randomized TrialKonstantin Zhdanov, Vasily Isakov, Eduard Burnevich, et al.
Medicinal Research Reviews|March 29, 2024
The menace of severe adverse events and deaths associated with viral gene therapy and its potential solutionArtyom Kachanov, Anastasiya Kostyusheva, Sergey Brezgin, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Lancet (London, England)|October 6, 2017
Tuberculosis and HIV/AIDS: the alien and the predatorVadim Pokrovsky
International Journal of Molecular Sciences|July 12, 2025
New Anticancer Agents: Design, Synthesis and EvaluationVadim Pokrovsky, Raffaele Addeo, Mauro Coluccia
F1000Research|June 26, 2023
Predictive value of <sup>18</sup>F-fluorodeoxyglucose accumulation in visceral fat activity to detect colorectal cancer metastases (prospective observational cohort study)Amil Suleimanov, Aigul Saduakassova, Denis Vinnikov, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|October 23, 2020
Power of two: combination of therapeutic approaches involving glucose transporter (GLUT) inhibitors to combat cancerKalpana Tilekar, Neha Upadhyay, Cristina V Iancu, et al.
Cells|February 7, 2018
Optimization of Polycistronic Anti-CCR5 Artificial microRNA Leads to Improved Accuracy of Its Lentiviral Vector Transfer and More Potent Inhibition of HIV-1 in CD4⁺ T-CellsFelix Urusov, Dina Glazkova, Denis Omelchenko, et al.
Microorganisms|November 27, 2021
Dynamics of Plasmatic Levels of Pro- and Anti-Inflammatory Cytokines in HIV-Infected Individuals with <i>M. tuberculosis</i> Co-InfectionMarina Nosik, Konstantin Ryzhov, Irina Rymanova, et al.
Virus Evolution|July 1, 2022
Molecular epidemiology of HIV-1 in Oryol Oblast, RussiaKsenia R Safina, Yulia Sidorina, Natalya Efendieva, et al.
Cancer Communications (London, England)|October 17, 2022
Cell models with inducible oncogenic translocations allow to evaluate the potential of drugs to favor secondary translocationsAnna Shmakova, Nikolai Lomov, Vladimir Viushkov, et al.
Hepatic Medicine : Evidence and Research|May 6, 2020
Elbasvir/Grazoprevir for HCV Infection in Russia: A Randomized TrialKonstantin Zhdanov, Vasily Isakov, Eduard Burnevich, et al.
Medicinal Research Reviews|March 29, 2024
The menace of severe adverse events and deaths associated with viral gene therapy and its potential solutionArtyom Kachanov, Anastasiya Kostyusheva, Sergey Brezgin, et al.
Pageof 3